Search
Trifluoroethanol
go.drugbank.com/drugs/DB03226ExperimentalA non-aqueous co-solvent that serves as tool to study protein folding. It is also used in various pharmaceutical, chemical and engineering applications.
2'-Deoxycytidine 5'-triphosphate
go.drugbank.com/drugs/DB03258ExperimentalSynonyms: 2'-Deoxycytidine 5'-triphosphate, 2'-Deoxycytidine-5'-TriphosphateCategories: Heterocyclic Compounds, 1-RingGlutaral
go.drugbank.com/drugs/DB03266InvestigationalOne of the protein CROSS-LINKING REAGENTS that is used as a disinfectant for sterilization of heat-sensitive equipment and as a laboratory reagent, especially as a fixative.
Categories: Compounds used in a research, industrial, or household settingBrivudine
go.drugbank.com/drugs/DB03312ApprovedInvestigationalBrivudine is used in the treatment of herpes zoster. Although not approved in the U.S. or Canada, it is approved in several European countries.
Synonyms: (E)-5-(2-Bromovinyl)-deoxyuridineCategories: Heterocyclic Compounds, 1-RingCephalosporin C
go.drugbank.com/drugs/DB03313ExperimentalSynonyms: 7-(5-Amino-5-carboxyvaleramido)cephalosporanic acid, Cephalosporin CCategories: Heterocyclic Compounds, 2-RingGuanosine 3'-monophosphate
go.drugbank.com/drugs/DB03315ExperimentalSynonyms: 3'-GMP, 3'-Guanylic acidCategories: Heterocyclic Compounds, 2-RingTetramisole
go.drugbank.com/drugs/DB16561InvestigationalTetramisole is an anthelmintic agent.
Categories: Heterocyclic Compounds, 1-RingAlmonertinib
go.drugbank.com/drugs/DB16640ApprovedInvestigational[A231859, A231864, A231869] Unlike other third-generation EGFR TKIs, almonertinib is a pyrimidine-based drug that forms a covalent bond to the binding site of the EGFR tyrosine kinase domain. … Almonertinib is a third-generation EGFR tyrosine kinase inhibitor targeting EGFR-sensitizing and T790M resistance mutations.
Synonyms: 2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, N-[5-[[4-(1-Cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-2-propenamideCategories: MATE 1 Inhibitors, P-glycoprotein inhibitorsRemibrutinib
go.drugbank.com/drugs/DB16852ApprovedInvestigational[L54101] Bruton's tyrosine kinase plays a role in B cell receptor and Fc receptor signalling, releasing histamine and pro-inflammatory mediators. … Remibrutinib is a selective Bruton's tyrosine kinase inhibitor. The FDA approved remibrutinib on September 30, 2025 as the only oral, targeted treatment for chronic spontaneous urticaria.
Categories: MATE 1 Inhibitors, P-glycoprotein inhibitors